RAMM Pharma Corp.
RAMM
CNSX
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -6.30M | -6.24M | -6.40M | -9.66M | -10.00M |
| Total Depreciation and Amortization | 359.50K | 441.40K | 521.70K | 640.20K | 754.00K |
| Total Amortization of Deferred Charges | 1.70K | 1.30K | 800.00 | 1.10K | 700.00 |
| Total Other Non-Cash Items | 3.31M | 2.95M | 3.22M | 6.15M | 6.04M |
| Change in Net Operating Assets | 1.45M | 2.03M | 1.91M | 1.72M | 1.40M |
| Cash from Operations | -1.17M | -817.50K | -753.10K | -1.14M | -1.81M |
| Capital Expenditure | -- | 17.60K | 0.00 | -16.00K | -25.10K |
| Sale of Property, Plant, and Equipment | 778.00K | 1.27M | 862.90K | 593.10K | 556.40K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -5.00K | -10.60K |
| Cash from Investing | 778.00K | 1.29M | 862.90K | 572.10K | 520.70K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -69.80K | -101.20K | -145.50K | -214.20K | -255.30K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -8.60K | -8.60K | -8.60K | 16.40K | 16.20K |
| Cash from Financing | -57.20K | -78.90K | -109.40K | -141.50K | -171.80K |
| Foreign Exchange rate Adjustments | -5.80K | -28.10K | -8.40K | -7.70K | -3.90K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -458.40K | 360.80K | -7.80K | -714.20K | -1.46M |